|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0820 AUD | 0.00% |
|
+2.50% | -3.53% |
| 02/01 | FDA Denies Neurizon Therapeutics' Request for Fast Track Designation for ALS Treatment Candidate | MT |
| 02/01 | Neurizon Therapeutics says US FDA denies Fast Track designation for NUZ-001 | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEURIZON THERAPEUTICS LIMITED | Other Pharmaceuticals | 0.00% | +2.50% | -3.53% | -50.30% | -15.46% | 3.37Cr |
- Stock Market
- Equities
- NUZ Stock
- Charts Neurizon Therapeutics Limited
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















